PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank64
3Y CAGR+2.1%
5Y CAGR+2.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+2.1%/yr
vs -7.2%/yr prior
5Y CAGR
+2.2%/yr
Consistent
Acceleration
+9.3pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.94M | -35.6% |
| 2024 | $6.11M | +2.1% |
| 2023 | $5.99M | +61.8% |
| 2022 | $3.70M | +36.7% |
| 2021 | $2.71M | -23.2% |
| 2020 | $3.53M | -3.2% |
| 2019 | $3.64M | -26.9% |
| 2018 | $4.98M | +52.9% |
| 2017 | $3.26M | -30.1% |
| 2016 | $4.67M | - |